TD Asset Management’s Arcus Biosciences RCUS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-23,500
| Closed | -$477K | – | 1441 |
|
2023
Q2 | $477K | Buy |
23,500
+8,100
| +53% | +$165K | ﹤0.01% | 1276 |
|
2023
Q1 | $281K | Sell |
15,400
-46,900
| -75% | -$855K | ﹤0.01% | 1348 |
|
2022
Q4 | $1.29M | Buy |
+62,300
| New | +$1.29M | ﹤0.01% | 1097 |
|
2019
Q1 | – | Sell |
-20,758
| Closed | -$224K | – | 1385 |
|
2018
Q4 | $224K | Sell |
20,758
-2,003
| -9% | -$21.6K | ﹤0.01% | 1342 |
|
2018
Q3 | $317K | Sell |
22,761
-6,497
| -22% | -$90.5K | ﹤0.01% | 1362 |
|
2018
Q2 | $358K | Hold |
29,258
| – | – | ﹤0.01% | 1334 |
|
2018
Q1 | $452K | Buy |
+29,258
| New | +$452K | ﹤0.01% | 1223 |
|